Circulating chemerin decreases in response to a combined strength and endurance training

Tsvetan Stefanov1, Matthias Blüher, Anna Vekova

  • 1Medicobiological Unit, International Scientific Institute, National Sports Academy, Studentski Grad, 1700, Sofia, Bulgaria, tsvetan.stefanov@gmail.com.

Endocrine
|June 21, 2013
PubMed

Insights

Chemerin, linked to obesity and inflammation, was associated with cardiometabolic risks. A 6-month exercise program significantly reduced chemerin levels in overweight individuals, improving insulin resistance.

Area of Science:

  • Endocrinology and Metabolism
  • Exercise Physiology
  • Obesity Research

Background:

  • Chemerin, an adipokine, is implicated in obesity, inflammation, insulin resistance, and cardiovascular disease.
  • Understanding chemerin's role in cardiometabolic risk factors is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate the association between serum chemerin and cardiometabolic risk factors in a cross-sectional study.
  • To evaluate the effect of a 6-month combined exercise program on serum chemerin levels in overweight/obese, non-diabetic individuals.

Main Methods:

  • Cross-sectional analysis of 98 individuals assessing chemerin and various cardiometabolic parameters.
  • Intervention study with 79 sedentary, overweight/obese, non-diabetic participants in a 6-month combined exercise program (n=51) or control group (n=28).
  • Serum chemerin, lipids, glucose, insulin, HOMA-IR, blood pressure, hs-CRP, leucocytes, and leptin were measured.

Main Results:

  • Chemerin showed significant associations with total cholesterol, triglycerides, fasting insulin, HOMA-IR, systolic blood pressure, hs-CRP, leucocytes, and leptin, independent of age and BMI.
  • Chemerin was an independent determinant of HOMA-IR in multiple regression analysis.
  • The 6-month exercise program significantly reduced serum chemerin levels (p < 0.001) and improved HOMA-IR, with changes in chemerin correlating with HOMA-IR improvements.

Conclusions:

  • Serum chemerin is associated with multiple cardiometabolic risk factors in non-diabetic individuals, independent of BMI.
  • A 6-month combined exercise program effectively reduces circulating chemerin levels in overweight or obese individuals.
  • Exercise-induced reduction in chemerin may contribute to improved insulin sensitivity.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Exercise and Muscle Performance01:27

Exercise and Muscle Performance

Exercise induces a range of adaptations in muscle tissue, depending on the type and duration of activity. Such physical training can be broadly categorized into two types: endurance exercises and resistance exercises.
Endurance exercises
Endurance exercises involve running, swimming, or cycling, which require repetitive movements with low force output. When a person engages in endurance exercise, a few noticeable changes occur in their skeletal muscles. For instance, the number of capillaries...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...